NCT02410850 Long Term Oral Appliance Therapy Effectiveness for Obstructive Sleep Apnea Syndrome
| NCT ID | NCT02410850 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of British Columbia |
| Condition | Obstructive Sleep Apnea |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2018-04-01 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2018-04-01 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Obstructive sleep apnea (OSA) is a highly prevalent breathing problem that occurs during sleep. OSA have been associated with the obesity epidemic in developing countries; additionally, high OSA prevalence rates are present in populations with cardiovascular and metabolic disorders. Two OSA treatments are currently available, oral appliance (OA) therapy and continuous positive airway pressure (CPAP). OAs are an underutilized non-surgical treatment and few studies have analyzed their long-term effectiveness for patients with OSA. The purpose of this study is to assess the long-term effectiveness of OA therapy in patients with OSA and to explore any changes on cardiovascular related morbidity and mortality related to this therapy.
Eligibility Criteria
Inclusion Criteria: * Patients are currently prescribed Oral Appliance for their Obstructive Sleep Apnea Exclusion Criteria: * Patients under the age of 18 years. * Patients that do not understand the English language. * Patients that refuse to sign the informed consent for any reason.
Contact & Investigator
Fernanda Almeida, DDS,Phd
PRINCIPAL INVESTIGATOR
University of British Columbia
Frequently Asked Questions
Who can join the NCT02410850 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Obstructive Sleep Apnea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02410850 currently recruiting?
Yes, NCT02410850 is actively recruiting participants. Contact the research team at falmeida@dentistry.ubc.ca for enrollment information.
Where is the NCT02410850 trial being conducted?
This trial is being conducted at Vancouver, Canada.
Who is sponsoring the NCT02410850 clinical trial?
NCT02410850 is sponsored by University of British Columbia. The principal investigator is Fernanda Almeida, DDS,Phd at University of British Columbia. The trial plans to enroll 1,000 participants.